Skip to search.
 TSX Down 0.02% TSX Ventures Up 1.40%

More On TTHI

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
1.59 Down 0.03(1.85%) 3:45PM EDT
Prev Close:1.62
Open:1.62
Bid:1.59 x 100
Ask:1.61 x 200
1y Target Est:1.81
Beta:2.56484
Next Earnings Date:N/A
Day's Range:1.58 - 1.62
52wk Range:0.66 - 2.75
Volume:6,040
Avg Vol (3m):88,064
Market Cap:61.82M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-0.28
Quarterly EPS Est (Sep-15) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback